Physician profile
Suzanne Ward
NPI 1144395120
$1,362.87
in general payments reported to CMS, 2019-2025
20 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $324 · 2023: $733 · 2024: $201 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $266.53 | 2023 | Proclaim, Eterna |
| Scilex Pharmaceuticals INC. | $205.49 | 2022-2024 | Ztlido |
| Nevro Corp. | $108.53 | 2023 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $99.88 | 2022 | |
| Medtronic, INC. | $96.55 | 2022 | |
| Protega Pharmaceutials INC | $87.98 | 2024 | Roxybond |
| Pfizer INC. | $71.07 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $70.93 | 2023-2025 | Exparel, Iovera, Zilretta |
| Averitas Pharma INC. | $68.77 | 2023-2024 | Qutenza |
| Collegium Pharmaceutical, INC. | $47.09 | 2022-2023 | Belbuca |
| Nalu Medical, INC. | $36.46 | 2022-2023 | Nalu Neurostimulation System |
| Lilly USA, LLC | $26.52 | 2022-2023 | Emgality |
| Abbvie INC. | $25.91 | 2023 | |
| Acera Surgical, INC. | $24.79 | 2025 | Restrata Wound Matrix |
| Merck Sharp & Dohme LLC | $23.32 | 2024 | Keytruda |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $22.80 | 2022 | |
| Aimmune Therapeutics, INC. | $20.70 | 2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.51 | 2023 | Relistor |
| Si-Bone, INC. | $19.83 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.21 | 2025 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.